418 related articles for article (PubMed ID: 21076528)
1. The role of HDAC6 in cancer.
Aldana-Masangkay GI; Sakamoto KM
J Biomed Biotechnol; 2011; 2011():875824. PubMed ID: 21076528
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K
J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6.
Qu X; Du J; Zhang C; Fu W; Xi H; Zou J; Hou J
PLoS One; 2012; 7(2):e32215. PubMed ID: 22384180
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 6 in cancer.
Li T; Zhang C; Hassan S; Liu X; Song F; Chen K; Zhang W; Yang J
J Hematol Oncol; 2018 Sep; 11(1):111. PubMed ID: 30176876
[TBL] [Abstract][Full Text] [Related]
5. Curcumin augments the efficacy of antitumor drugs used in leukemia by modulation of heat shock proteins via HDAC6.
Sarkar R; Mukherjee A; Mukherjee S; Biswas R; Biswas J; Roy M
J Environ Pathol Toxicol Oncol; 2014; 33(3):247-63. PubMed ID: 25272063
[TBL] [Abstract][Full Text] [Related]
6. Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design.
Peng J; Xie F; Qin P; Liu Y; Niu H; Sun J; Xue H; Zhao Q; Liu J; Wu J
Bioorg Chem; 2023 Sep; 138():106622. PubMed ID: 37244230
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 6 in health and disease.
Seidel C; Schnekenburger M; Dicato M; Diederich M
Epigenomics; 2015; 7(1):103-18. PubMed ID: 25687470
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase 6 regulates cytotoxic α-synuclein accumulation through induction of the heat shock response.
Du Y; Wang F; Zou J; Le W; Dong Q; Wang Z; Shen F; Yu L; Li Y
Neurobiol Aging; 2014 Oct; 35(10):2316-28. PubMed ID: 24866403
[TBL] [Abstract][Full Text] [Related]
9. HDAC6: physiological function and its selective inhibitors for cancer treatment.
Yang PH; Zhang L; Zhang YJ; Zhang J; Xu WF
Drug Discov Ther; 2013 Dec; 7(6):233-42. PubMed ID: 24423654
[TBL] [Abstract][Full Text] [Related]
10. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90.
Liu P; Xiao J; Wang Y; Song X; Huang L; Ren Z; Kitazato K; Wang Y
Mol Med; 2021 Sep; 27(1):110. PubMed ID: 34530730
[TBL] [Abstract][Full Text] [Related]
11. The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response.
Kwon S; Zhang Y; Matthias P
Genes Dev; 2007 Dec; 21(24):3381-94. PubMed ID: 18079183
[TBL] [Abstract][Full Text] [Related]
12. Cellular defence or viral assist: the dilemma of HDAC6.
Zheng K; Jiang Y; He Z; Kitazato K; Wang Y
J Gen Virol; 2017 Mar; 98(3):322-337. PubMed ID: 27959772
[TBL] [Abstract][Full Text] [Related]
13. HDAC6 modulates cell motility by altering the acetylation level of cortactin.
Zhang X; Yuan Z; Zhang Y; Yong S; Salas-Burgos A; Koomen J; Olashaw N; Parsons JT; Yang XJ; Dent SR; Yao TP; Lane WS; Seto E
Mol Cell; 2007 Jul; 27(2):197-213. PubMed ID: 17643370
[TBL] [Abstract][Full Text] [Related]
14. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
[TBL] [Abstract][Full Text] [Related]
15. Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90.
Fiskus W; Ren Y; Mohapatra A; Bali P; Mandawat A; Rao R; Herger B; Yang Y; Atadja P; Wu J; Bhalla K
Clin Cancer Res; 2007 Aug; 13(16):4882-90. PubMed ID: 17699868
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis.
Gao YS; Hubbert CC; Lu J; Lee YS; Lee JY; Yao TP
Mol Cell Biol; 2007 Dec; 27(24):8637-47. PubMed ID: 17938201
[TBL] [Abstract][Full Text] [Related]
17. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates.
Boyault C; Zhang Y; Fritah S; Caron C; Gilquin B; Kwon SH; Garrido C; Yao TP; Vourc'h C; Matthias P; Khochbin S
Genes Dev; 2007 Sep; 21(17):2172-81. PubMed ID: 17785525
[TBL] [Abstract][Full Text] [Related]
18. The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis.
Lee YS; Lim KH; Guo X; Kawaguchi Y; Gao Y; Barrientos T; Ordentlich P; Wang XF; Counter CM; Yao TP
Cancer Res; 2008 Sep; 68(18):7561-9. PubMed ID: 18794144
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer.
Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Chang YG; Kim MG; Park WS; Lee JY; Lee SY; Chu IS; Nam SW
Hepatology; 2012 Aug; 56(2):644-57. PubMed ID: 22392728
[TBL] [Abstract][Full Text] [Related]
20. Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90).
Bonanni D; Citarella A; Moi D; Pinzi L; Bergamini E; Rastelli G
Curr Med Chem; 2022; 29(9):1474-1502. PubMed ID: 34477503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
